Moreover, we observed genomic amplification and higher expression of TLK1 and one of its key downstream effector kinases—MK5—in metastatic PCa through our interrogation of TCGA, SU2C, and other public PCa patient databases [15]. This evidence concerns the gene TLK1 and posterior cortical atrophy.